 | 2022 | Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real‑world observational study | Alcalá, Carmen; Quintanilla-Bordás, Carlos; Gascón, Francisco; Perez-Sempere, Angel; Navarro, Laura; Carcelén‑Gadea, María; Landete, Lamberto; Mallada, Javier; Cañizares, Emmanuel; Belenguer, Antonio; Carratalá, Sara; Domínguez, José Andrés; Pérez‑Miralles, Francisco Carlos; Gil‑Perotín, Sara; Gasqué, Raquel; Cubas, Laura; Castillo, Jéssica; Casanova, Bonaventura |  |